Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, today announced key results from its Phase II clinical trial ...
Researchers at the Perelman School of Medicine at the University of Pennsylvania report that adults with seborrheic ...
Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind ...
An open-source platform enables multinational analysis of dermatology registries for atopic dermatitis while safeguarding ...
Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...
Roskin and a team of 19 experts in asthma, biomedical informatics, genetics, and immunology discovered that children with ...
Kids are trying to get their hands on the next trendy skincare product on TikTok, and experts are concerned. Amber Raiken ...
Discover how endolysin therapy targets Staphylococcus aureus to safely relieve inflammation and restore skin health in atopic ...
Discover a study revealing how seborrheic dermatitis is linked to multiple epithelial barrier diseases, supporting the ...
Understand options for fast and effective management of pruritus for cases of canine atopic dermatitis. Identify limitations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback